Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: a report from the EBMT Lymphoma Working Party - Bazarbachi, Ali; Dreger, Peter (Cancer, 2018)
Published online October 23, 2018